HAVLF (HAVLF) Stock Price & Analysis
HAVLF (HAVLF) rose 0.00% to USD 0 as of June 10, 2026 at 07:11 UTC, according to Nexqual real-time market data.
HAVLF last closed at USD 0; the session ranged USD 0.01–0.01 on volume of 22,105 shares. Market capitalization is $1,473, with a 52-week range of USD 0–0.01 (PNK). Source: Nexqual, June 10, 2026 at 07:11 UTC.
Key Statistics (as of June 10, 2026 at 07:11 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0.01 |
| Day Range | USD 0.01 – 0.01 |
| 52-Week Range | USD 0 – 0.01 |
| Volume | 22,105 shares |
| Market Cap | $1,473 |
| Exchange | PNK |
Technical Analysis (HAVLF)
Nexqual's technical model rates HAVLF "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 07:11 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (HAVLF)
Wall Street analysts rate HAVLF "None", per Nexqual as of June 10, 2026 at 07:11 UTC.
| Consensus Rating | None |
|---|
Earnings (HAVLF)
Source: Nexqual, June 10, 2026 at 07:11 UTC.
Financials & Fundamentals (HAVLF)
| Total Revenue | $586,976 |
|---|---|
| Gross Margin | +35.54% |
| Operating Margin | +5362.73% |
| Profit Margin | +0.00% |
| ROE | -234.52% |
| Debt / Equity | 3.13 |
| Current Ratio | 2.68 |
| Total Cash | $13,986 |
| Total Debt | $26,234 |
| Free Cash Flow | $-708,919 |
Source: Nexqual, June 10, 2026 at 07:11 UTC.
Financial Health Score (HAVLF)
Nexqual rates HAVLF's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 07:11 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Strong — $14K cash, no debt |
| Cash Flow | Weak — FCF negative: -$709K, burning cash |
| Efficiency | Critical — ROE -235%, ROA -30.3% |
Ownership (HAVLF)
| Insider Ownership | +3.50% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 14.74M |
| Float | 14.22M |
Source: Nexqual, June 10, 2026 at 07:11 UTC.
Leadership (HAVLF)
HAVLF is led by Tim Moore (age 66), Interim CFO, CEO & Chairman, per Nexqual as of June 10, 2026 at 07:11 UTC.
| Interim CFO, CEO & Chairman | Tim Moore (age 66) |
|---|
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MYCOF | MYDECINE INNOVATIONS GROUP INC | USD 2 | ▲ 0% |
| EHVVF | Ehave Inc. | USD 0 | ▲ 0% |
| RVVTF | Revive Therapeutics Ltd. | USD 0.03 | ▲ 15.45% |
| TRUFF | Red Light Holland Corp. | USD 0.03 | ▲ 0.71% |
| BRAXF | Braxia Scientific Corp. | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 07:11 UTC. This page is informational and not investment advice.